Total Payments
$173,977
2024 Payments
$68,072
Companies
31
Transactions
412
Medicare Patients
9,339
Medicare Billing
$1.5M
Payment Breakdown by Category
Other$100,151 (57.6%)
Consulting$37,864 (21.8%)
Travel$21,442 (12.3%)
Food & Beverage$14,502 (8.3%)
Education$17.84 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100,125 | 45 | 57.6% |
| Consulting Fee | $37,864 | 16 | 21.8% |
| Travel and Lodging | $21,442 | 51 | 12.3% |
| Food and Beverage | $14,502 | 298 | 8.3% |
| Honoraria | $25.59 | 1 | 0.0% |
| Education | $17.84 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $117,791 | 183 | $0 (2024) |
| Glaukos Corporation | $16,894 | 48 | $0 (2024) |
| RxSight Inc | $12,180 | 10 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $10,414 | 40 | $0 (2024) |
| Alcon Vision LLC | $7,970 | 27 | $0 (2024) |
| Allergan, Inc. | $4,132 | 28 | $0 (2022) |
| LENSAR, Inc. | $1,592 | 7 | $0 (2024) |
| Dompe US, Inc. | $348.84 | 9 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $337.67 | 3 | $0 (2023) |
| BIOTISSUE HOLDINGS INC. | $316.26 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68,072 | 152 | ABBVIE INC. ($45,117) |
| 2023 | $54,955 | 113 | AbbVie Inc. ($40,473) |
| 2022 | $48,319 | 75 | ABBVIE INC. ($32,200) |
| 2021 | $568.54 | 28 | Aerie Pharmaceuticals, Inc. ($216.74) |
| 2020 | $471.05 | 15 | Alcon Vision LLC ($186.74) |
| 2019 | $735.79 | 13 | Alcon Vision LLC ($317.79) |
| 2018 | $482.05 | 13 | Glaukos Corporation ($305.81) |
| 2017 | $374.08 | 3 | Johnson & Johnson Surgical Vision, Inc. ($135.01) |
All Payment Transactions
412 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 12/17/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $34.87 | General |
| Category: EYE CARE | ||||||
| 12/17/2024 | Rayner Intraocular Lenses Limited | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $27.75 | General |
| Category: Ophthalmology | ||||||
| 12/16/2024 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Clearpath, Ahmed Glaucoma Valve | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Ophthalmology | ||||||
| 12/13/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $34.95 | General |
| Category: EYE CARE | ||||||
| 12/10/2024 | ABBVIE INC. | DURYSTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: EYE CARE | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Travel and Lodging | In-kind items and services | $253.12 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $119.41 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $50.75 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Travel and Lodging | In-kind items and services | $253.12 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $114.40 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $158.13 | General |
| 11/25/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: EYE CARE | ||||||
| 11/20/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: EYE CARE | ||||||
| 11/20/2024 | ABBVIE INC. | DURYSTA (Drug) | Travel and Lodging | In-kind items and services | $96.48 | General |
| Category: EYE CARE | ||||||
| 11/20/2024 | ABBVIE INC. | DURYSTA (Drug) | Travel and Lodging | In-kind items and services | $16.00 | General |
| Category: EYE CARE | ||||||
| 11/18/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $34.40 | General |
| Category: Glaucoma | ||||||
| 11/12/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: EYE CARE | ||||||
| 11/05/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $25.07 | General |
| Category: Glaucoma | ||||||
| 11/01/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: SOLUTION/ DROPS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,418 | 4,112 | $1.0M | $442,957 |
| 2022 | 22 | 2,824 | 4,504 | $1.1M | $512,593 |
| 2021 | 19 | 2,412 | 3,096 | $931,395 | $352,693 |
| 2020 | 19 | 1,685 | 2,193 | $578,769 | $234,637 |
Total Patients
9,339
Total Services
13,905
Medicare Billing
$1.5M
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J7351 | Injection, bimatoprost, intracameral implant, 1 microgram | Office | 2023 | 55 | 890 | $222,500 | $143,830 | 64.6% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 162 | 266 | $372,400 | $102,155 | 27.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 495 | 1,008 | $114,710 | $58,213 | 50.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 120 | 169 | $69,251 | $40,424 | 58.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 171 | 171 | $34,769 | $14,587 | 42.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 170 | 172 | $28,559 | $13,752 | 48.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 262 | 286 | $33,496 | $12,170 | 36.3% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 42 | 69 | $32,044 | $11,848 | 37.0% |
| 66991 | Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | Facility | 2023 | 16 | 22 | $17,813 | $11,319 | 63.5% |
| 66030 | Injection of medication into eye | Office | 2023 | 55 | 89 | $19,867 | $11,217 | 56.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 221 | 313 | $39,591 | $8,844 | 22.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 251 | 254 | $17,943 | $5,762 | 32.1% |
| 92250 | Photography of the retina | Office | 2023 | 183 | 184 | $19,434 | $4,213 | 21.7% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 43 | 43 | $4,647 | $2,290 | 49.3% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 106 | 106 | $2,276 | $826.82 | 36.3% |
| 92134 | Imaging of retina | Office | 2023 | 32 | 33 | $2,331 | $768.00 | 32.9% |
| 92025 | Ct scan of cornea | Office | 2023 | 22 | 24 | $1,200 | $512.26 | 42.7% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 12 | 13 | $500.37 | $227.48 | 45.5% |
| J7351 | Injection, bimatoprost, intracameral implant, 1 microgram | Office | 2022 | 46 | 881 | $222,500 | $143,436 | 64.5% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 155 | 253 | $354,200 | $106,714 | 30.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 525 | 1,003 | $114,141 | $64,962 | 56.9% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 83 | 115 | $46,846 | $30,532 | 65.2% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 259 | 259 | $52,662 | $23,209 | 44.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 219 | 227 | $37,691 | $18,939 | 50.2% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2022 | 49 | 82 | $38,081 | $16,517 | 43.4% |
About Dr. John Stephens, M.D
Dr. John Stephens, M.D is a Ophthalmology healthcare provider based in Cape Coral, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2014. The National Provider Identifier (NPI) number assigned to this provider is 1134549967.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Stephens, M.D has received a total of $173,977 in payments from pharmaceutical and medical device companies, with $68,072 received in 2024. These payments were reported across 412 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($100,125).
As a Medicare-enrolled provider, Stephens has provided services to 9,339 Medicare beneficiaries, totaling 13,905 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Cape Coral, FL
- Active Since 04/19/2014
- Last Updated 09/01/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134549967
Products in Payments
- DURYSTA (Drug) $121,410
- iDose (Device) $9,061
- STELLARIS ELITE (Device) $8,306
- RXSIGHT CONTACT LENS (Device) $7,088
- Clareon (Device) $5,399
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) $4,960
- iStent inject Trabecular Micro-Bypass System Model G2-M-IS (Device) $2,750
- enVista Aspire IOL (Device) $1,863
- AcrySof IQ PanOptix UV IOL (Device) $1,710
- ISTENT INJECT W (Device) $1,617
- LENSAR LASER SYSTEM (Device) $1,592
- iStent Trabecular Micro-Bypass System Model iS3 (Device) $1,160
- iStent infinite Trabecular Micro-Bypass System Model iS3 (Device) $1,154
- Centurion (Device) $351.56
- OXERVATE (Drug) $314.16
- AcrySof IQ PanOptix (Device) $237.62
- XEN (Device) $225.87
- EVA, combined machine (Device) $194.62
- VYZULTA (Drug) $176.03
- rhopressa (Drug) $175.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.